Femanor Tafla 2 mg+1 mg איסלנד - איסלנדית - LYFJASTOFNUN (Icelandic Medicines Agency)

femanor tafla 2 mg+1 mg

viatris aps - norethisteronum acetat; estradiol - tafla - 2 mg+1 mg

Novofem Filmuhúðuð tafla איסלנד - איסלנדית - LYFJASTOFNUN (Icelandic Medicines Agency)

novofem filmuhúðuð tafla

novo nordisk a/s* - estradiol; norethisteronum acetat - filmuhúðuð tafla

Pulmozyme Lausn í eimgjafa 1 mg/ml איסלנד - איסלנדית - LYFJASTOFNUN (Icelandic Medicines Agency)

pulmozyme lausn í eimgjafa 1 mg/ml

roche pharmaceuticals a/s - dornase alfa inn - lausn í eimgjafa - 1 mg/ml

Wellbutrin Retard Tafla með breyttan losunarhraða 150 mg איסלנד - איסלנדית - LYFJASTOFNUN (Icelandic Medicines Agency)

wellbutrin retard tafla með breyttan losunarhraða 150 mg

glaxosmithkline pharma a/s - bupropionum hýdróklóríð - tafla með breyttan losunarhraða - 150 mg

Wellbutrin Retard Tafla með breyttan losunarhraða 300 mg איסלנד - איסלנדית - LYFJASTOFNUN (Icelandic Medicines Agency)

wellbutrin retard tafla með breyttan losunarhraða 300 mg

glaxosmithkline pharma a/s - bupropionum hýdróklóríð - tafla með breyttan losunarhraða - 300 mg

Tyruko האיחוד האירופי - איסלנדית - EMA (European Medicines Agency)

tyruko

sandoz gmbh - natalízúmab - multiple sclerosis, relapsing-remitting; multiple sclerosis - Ónæmisbælandi lyf - tyruko is indicated as single disease modifying therapy in adults with highly active relapsing remitting multiple sclerosis (rrms) for the following patient groups: patients with highly active disease despite a full and adequate course of treatment with at least one disease modifying therapy (dmt) (for exceptions and information about washout periods see sections 4. 4 og 5. 1), or, patients with rapidly evolving severe rrms defined by 2 or more disabling relapses in one year, and with 1 or more gadolinium enhancing lesions on brain magnetic resonance imaging (mri) or a significant increase in t2 lesion load as compared to a previous recent mri.

Bupropion Teva Tafla með breyttan losunarhraða 150 mg איסלנד - איסלנדית - LYFJASTOFNUN (Icelandic Medicines Agency)

bupropion teva tafla með breyttan losunarhraða 150 mg

teva b.v.* - bupropionum hýdróklóríð - tafla með breyttan losunarhraða - 150 mg

Cytopoint האיחוד האירופי - איסלנדית - EMA (European Medicines Agency)

cytopoint

zoetis belgium sa - lokivetmab - Önnur húð undirbúningur, lyfjum fyrir exem, án krefur - hundar - meðferð á klínískum einkennum ofnæmishúðbólgu hjá hundum.

Exzolt האיחוד האירופי - איסלנדית - EMA (European Medicines Agency)

exzolt

intervet international b.v. - fluralaner - ectoparaciticides, skordýraeitur og repellents - kjúklingur - meðferð á rauðum mýkjum alifugla (dermanyssus gallinae) sýkingar í drekum, ræktendum og laghærum.